Cargando…
BSCI-04 TARGETING THE PI3K-MTOR PATHWAY TO TREAT UBE2C-DRIVEN BRAIN METASTASES
Brain metastases (BMs) are a devastating complication of advanced cancers associated with poor prognosis. Contrarily to the current improvement in systemic therapies, BMs are still incurable and one of the main causes of death in cancer patients. We analyzed BMs from thirty patients with various pri...
Autores principales: | Paisana, Eunice, Cascão, Rita, Custódia, Carlos, Qin, Nan, Picard, Daniel, Pauck, David, Carvalho, Tânia, Ruivo, Pedro, Roque, Rafael, Pimentel, José, Remke, Marc, Barata, João T, Faria, Cláudia C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354218/ http://dx.doi.org/10.1093/noajnl/vdac078.004 |
Ejemplares similares
-
LMD-12. Ubiquitin Conjugating Enzymes promote leptomeningeal dissemination and decrease survival in patients with brain metastatic disease
por: Paisana, Eunice, et al.
Publicado: (2021) -
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease
por: Paisana, Eunice, et al.
Publicado: (2023) -
Patient-derived models of brain metastases recapitulate human disseminated disease
por: Faria, Claudia C., et al.
Publicado: (2022) -
Role of UBE2C in Brain Cancer Invasion and Dissemination
por: Domentean, Stefani, et al.
Publicado: (2023) -
BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022)